Literature DB >> 10219065

Replacement of the aortic root in patients with Marfan's syndrome.

V L Gott1, P S Greene, D E Alejo, D E Cameron, D C Naftel, D C Miller, A M Gillinov, J C Laschinger, R E Pyeritz.   

Abstract

BACKGROUND: Replacement of the aortic root with a prosthetic graft and valve in patients with Marfan's syndrome may prevent premature death from rupture of an aneurysm or aortic dissection. We reviewed the results of this surgical procedure at 10 experienced surgical centers.
METHODS: A total of 675 patients with Marfan's syndrome underwent replacement of the aortic root. Survival and morbidity-free survival curves were calculated, and risk factors were determined from a multivariable regression analysis.
RESULTS: The 30-day mortality rate was 1.5 percent among the 455 patients who underwent elective repair, 2.6 percent among the 117 patients who underwent urgent repair (within 7 days after a surgical consultation), and 11.7 percent among the 103 patients who underwent emergency repair (within 24 hours after a surgical consultation). Of the 675 patients, 202 (30 percent) had aortic dissection involving the ascending aorta. Forty-six percent of the 158 adult patients with aortic dissection and a documented aortic diameter had an aneurysm with a diameter of 6.5 cm or less. There were 114 late deaths (more than 30 days after surgery); dissection or rupture of the residual aorta (22 patients) and arrhythmia (21 patients) were the principal causes of late death. The risk of death was greatest within the first 60 days after surgery, then rapidly decreased to a constant level by the end of the first year.
CONCLUSIONS: Elective aortic-root replacement has a low operative mortality. In contrast, emergency repair, usually for acute aortic dissection, is associated with a much higher early mortality. Because nearly half the adult patients with aortic dissection had an aortic-root diameter of 6.5 cm or less at the time of operation, it may be prudent to undertake prophylactic repair of aortic aneurysms in patients with Marfan's syndrome when the diameter of the aorta is well below that size.

Entities:  

Mesh:

Year:  1999        PMID: 10219065     DOI: 10.1056/NEJM199904293401702

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  78 in total

1.  [Surgical treatment of cardiovascular manifestations of Marfan's syndrome].

Authors:  R Lange; E Ebert
Journal:  Herz       Date:  1999-12       Impact factor: 1.443

Review 2.  Management of Marfan syndrome.

Authors:  John C S Dean
Journal:  Heart       Date:  2002-07       Impact factor: 5.994

3.  Endovascular therapy for thoracic aortic aneurysms: state of the art in 2012.

Authors:  Nicolas A Brozzi; Eric E Roselli
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

Review 4.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

Review 5.  Marfan's syndrome.

Authors:  Daniel P Judge; Harry C Dietz
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

Review 6.  Aneurysms of the ascending aorta.

Authors:  Daniel Lavall; Hans-Joachim Schäfers; Michael Böhm; Ulrich Laufs
Journal:  Dtsch Arztebl Int       Date:  2012-03-30       Impact factor: 5.594

7.  Beyond the root: dilatation of the distal aorta in Marfan's syndrome.

Authors:  P M Engelfriet; E Boersma; J G P Tijssen; B J Bouma; B J M Mulder
Journal:  Heart       Date:  2006-02-17       Impact factor: 5.994

Review 8.  Marfan syndrome: an update of genetics, medical and surgical management.

Authors:  Yskert von Kodolitsch; Peter N Robinson
Journal:  Heart       Date:  2007-06       Impact factor: 5.994

Review 9.  Open Versus Endovascular or Hybrid Thoracic Aortic Aneurysm Repair.

Authors:  Ryan Clare; Julianne Jorgensen; Somjot S Brar
Journal:  Curr Atheroscler Rep       Date:  2016-10       Impact factor: 5.113

Review 10.  Echocardiographic methods, quality review, and measurement accuracy in a randomized multicenter clinical trial of Marfan syndrome.

Authors:  Elif Seda Selamet Tierney; Jami C Levine; Shan Chen; Timothy J Bradley; Gail D Pearson; Steven D Colan; Lynn A Sleeper; M Jay Campbell; Meryl S Cohen; Julie De Backer; Lin T Guey; Haleh Heydarian; Wyman W Lai; Mark B Lewin; Edward Marcus; Christopher R Mart; Ricardo H Pignatelli; Beth F Printz; Angela M Sharkey; Girish S Shirali; Shubhika Srivastava; Ronald V Lacro
Journal:  J Am Soc Echocardiogr       Date:  2013-04-10       Impact factor: 5.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.